A Study of Megestrol Acetate in HIV-Infected Children
Not Applicable
Completed
- Conditions
- HIV Infections
- Registration Number
- NCT00002182
- Lead Sponsor
- Gamma Project - ACTU
- Brief Summary
The purpose of this study is to see if megestrol acetate is safe and effective in treating HIV-infected children with failure to thrive (FTT).
- Detailed Description
The study design is randomized, double-blind, placebo-controlled for 12 weeks with open-label drug offered after week 12.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Univ of Puerto Rico / Med Science Campus
🇵🇷San Juan, Puerto Rico